文献速递妇科

65岁及以上女性顶端脱垂术后再手术风险的纵向研究

Longitudinal Reoperation Risk After Apical Prolapse Procedures in Women Aged 65 Years and Older.
PubMed 文献 · Obstet Gynecol · 2024-01-16

这项全国性回顾性队列研究纳入2011年至2018年接受顶端盆腔器官脱垂手术的65岁及以上女性4089例,比较骶骨阴道固定术、子宫骶韧带悬吊术、骶棘韧带固定术和阴道封闭术的再手术风险。7年总体再手术风险从阴道封闭术的7.3%至骶棘韧带固定术的15.0%不等(P<.01)。手术修复类型与长期再手术风险显著相关。

要点

  • 7年总体再手术风险:阴道封闭术7.3%、子宫骶韧带悬吊术10.4%、骶骨阴道固定术12.5%、骶棘韧带固定术15.0%(P<.01)。
  • 7年脱垂复发再手术风险:阴道封闭术2.9%、骶骨阴道固定术7.3%、子宫骶韧带悬吊术7.7%、骶棘韧带固定术9.9%(P<.01)。
  • 7年并发症再手术风险:阴道封闭术5.3%、骶骨阴道固定术8.2%、子宫骶韧带悬吊术6.4%、骶棘韧带固定术8.2%(P<.01)。

核心结论

  • 手术修复类型与长期再手术风险显著相关。
  • 阴道封闭术再手术可能性最低,其次为骶骨阴道固定术;阴道封闭术其次为子宫骶韧带悬吊术的长期并发症再手术风险最低。

研究设计与样本

  • 全国性回顾性队列研究,纳入2011年1月1日至2018年12月31日期间接受顶端盆腔器官脱垂手术的65岁及以上女性,随访至2019年。
  • 数据来源于美国医疗保险和医疗补助服务中心(CMS)5%有限数据集(LDS)。
  • 共纳入4089例女性:骶骨阴道固定术1034例、子宫骶韧带悬吊术717例、骶棘韧带固定术1529例、阴道封闭术809例。
  • 主要结局为总体再手术,次要结局为盆腔器官脱垂再手术和并发症再手术。
  • 死亡和退出CMS保险作为删失事件。

主要发现

  • 不同手术患者的人口学特征存在差异:年龄(P<.01)、Charlson合并症指数评分(P<.01)、糖尿病(P<.01)、慢性阻塞性肺疾病(P<.01)、高血压(P<.01)、慢性疼痛(P=.01)、充血性心力衰竭(P<.01)和同期子宫切除术(P<.01)。
  • 再手术率较低且随时间增加。
  • 7年总体再手术风险:阴道封闭术7.3%、子宫骶韧带悬吊术10.4%、骶骨阴道固定术12.5%、骶棘韧带固定术15.0%(P<.01)。
  • 7年复发性盆腔器官脱垂再手术风险:阴道封闭术2.9%、骶骨阴道固定术7.3%、子宫骶韧带悬吊术7.7%、骶棘韧带固定术9.9%(P<.01)。
  • 7年并发症再手术风险:阴道封闭术5.3%、骶骨阴道固定术8.2%、子宫骶韧带悬吊术6.4%、骶棘韧带固定术8.2%(P<.01)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe longitudinal reoperation risk among older women undergoing surgery for apical pelvic organ prolapse (POP) and to compare risk of reoperation for prolapse and complications among different surgical approaches. METHODS: This nationwide, retrospective cohort study evaluated older adult women (aged 65 years and older) within the Centers for Medicare & Medicaid Services' (CMS) 5% LDS (Limited Data Set) who underwent sacrocolpopexy, uterosacral ligament suspension (USLS), sacrospinous ligament fixation (SSLF), or colpocleisis, or their uterine-preserving equivalents, from January 1, 2011, to December 31, 2018, with follow-up through 2019. The primary outcome was overall reoperation, and secondary outcomes included reoperation for POP and for complications. Rates were compared using χ 2 tests for categorical variables, Wilcoxon rank-sum for continuous variables and Kaplan Meier estimates of cumulative incidence. Death and exit from CMS insurance were considered as censoring events. We used cumulative incidence to calculate reoperation risk as a function of time at 1 year or more, 3 years or more, and 7 years or more. RESULTS: This cohort included 4,089 women who underwent surgery to treat apical POP from 2011 to 2018: 1,034 underwent sacrocolpopexy, 717 underwent USLS, 1,529 underwent SSLF, and 809 underwent colpocleisis. Demographics varied among patients for each POP surgery. Patients who underwent the different surgeries had differences in age ( P <.01), Charlson Comorbidity Index score ( P <.01), diabetes ( P <.01), chronic obstructive pulmonary disease ( P <.01), hypertension ( P <.01), chronic pain ( P =.01), congestive heart failure ( P <.01), and concomitant hysterectomy ( P <.01). Reoperation rates were low and increased over time. The overall reoperation risk through 7 years was 7.3% for colpocleisis, 10.4% for USLS, 12.5% for sacrocolpopexy, and 15.0% for SSLF ( P <.01). Reoperation for recurrent POP through 7 years was 2.9% for colpocleisis, 7.3% for sacrocolpopexy, 7.7% for USLS, and 9.9% for SSLF ( P <.01). Reoperation for complications through 7 years was 5.3% for colpocleisis, 8.2% for sacrocolpopexy, 6.4% for USLS, and 8.2% for SSLF ( P <.01). CONCLUSION: The type of surgical repair is significantly associated with long-term risk of reoperation. Colpocleisis offers the least likelihood of reoperation for prolapse, followed by sacrocolpopexy; colpocleisis followed by USLS has the least risk of long-term reoperation for complication.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Berger AA, Bretschneider CE, Gregory WT, et al. Longitudinal Reoperation Risk After Apical Prolapse Procedures in Women Aged 65 Years and Older. Obstet Gynecol. 2024. PMID: 38227947. doi:10.1097/AOG.0000000000005511

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。